Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of Fosinopril sodium
and hydrochlorothiazide 20-12.5 mg tablets of Ranbaxy laboratories Limited with that of
Monopril ® - HCT 20-12.5 mg tablets by Bristol Meyers Squibb following a single oral dose (1
x 20/12.5 mg tablet) in healthy adult subjects under non-fasting conditions.